←Cardiology & EP
Atrial fibrillation with RVR
📚
📚 Library › ❤️ Cardiology & EP › Arrhythmias
💓

Atrial fibrillation with RVR

Rate vs rhythm, which drug for which EF, cardioversion and the anticoagulation decision.

AFRVRCHA₂DS₂-VASccardioversion
🗓️ Reviewed 2026-11-18 · ⏱️ 6 min read · 📖 2023 ACC/AHA/ACCP/HRS AF guideline · 2024 ESC AF · 2025 AHA ACLS
🧠 Pathophysiology in 60 seconds🔎 Diagnosis & classification🧪 Workup — and why💊 Management⚠️ Pitfalls🎓 Board corner🏠 Discharge checklist📚 References
⚡ Bottom line — first hour
  • Unstable because of AF? (shock, ischemia, pulmonary edema) → synchronized cardioversion ≥200 J now.
  • Find the fire. Sepsis, bleed, hypovolemia, PE, pain, withdrawal, thyroid. Fast AF is often the alarm, not the fire.
  • Look for pre-excitation. Very fast (>250), wide, changing QRS → no AV nodal blockers.
  • Know the EF. EF >40% → metoprolol or diltiazem. EF ≤40% → no diltiazem; use amiodarone or digoxin.
  • Target resting HR <110 if symptoms are controlled.
  • Decide on anticoagulation today (CHA₂DS₂-VASc) — before any cardioversion, electrical or chemical.

🧠 Pathophysiology in 60 seconds

⌄
  • Trigger + substrate. Ectopic beats, mostly from the pulmonary veins, start AF. Stretched, scarred atria keep it going. AF remodels the atria → AF begets AF.
  • The AV node is the gatekeeper. Atria fire 350–600/min. The AV node lets only some through. Rate-control drugs act on the AV node.
  • Why patients crash. Fast rate shortens diastole → less LV filling and less coronary flow. Loss of the atrial kick hurts stiff ventricles most (HFpEF, AS, HCM).
  • Why strokes happen. No organized atrial contraction → stasis in the left atrial appendage → thrombus → embolism.
ATRIA 350–600 chaoticimpulses / min🎉🎉🎉 AV NODE"the bouncer"🕴️ VENTRICLESirregular100–180 / min💓 WPW: side door with no bouncer

Rate control makes the bouncer stricter (β-blocker, diltiazem, digoxin). In pre-excited AF, block the front door and the crowd rushes the side door → VF.

🧩 Think of it like this

The atria are a mosh pit. The AV node is the bouncer. Your drugs make the bouncer stricter. In WPW there is a side door with no bouncer — so do not block the front door.

🔎 Diagnosis & classification

⌄
II · AF with RVR — irregularly irregular, no P waves
Irregularly irregular R–R, no distinct P waves, fibrillatory baseline.
Schematic drawing · 25 mm/s · 10 mm/mV · swipe ↔
Element Criterion
ECG Irregularly irregular R–R, no repeating P waves
Duration needed Full 12-lead, or ≥30 s on a strip
"RVR" Ventricular rate >100–110/min

2023 ACC/AHA stages: 1 At risk → 2 Pre-AF → 3A Paroxysmal (≤7 d) · 3B Persistent (>7 d) · 3C Long-standing (>12 mo) · 3D after successful ablation → 4 Permanent.

Mimic Clue Why it matters
MAT ≥3 P-wave shapes, COPD Treat the lungs. No cardioversion, no OAC for MAT
Flutter, variable block Sawtooth in II, III, aVF Same OAC rules; ablation often cures
Sinus tach + PACs P before each QRS Treat the cause
Pre-excited AF Very fast, wide, bizarre QRS AV nodal blockers → VF

🧪 Workup — and why

⌄
Test What it changes
12-lead ECG Pre-excitation, ischemia, baseline QTc
BMP + Mg Replete K >4, Mg >2; CrCl for DOAC dosing
TSH Thyrotoxicosis → propranolol, treat thyroid
CBC Bleeding source; OAC bleeding risk
Troponin Only if chest pain / ischemic ECG — a flat bump is usually demand
TTE EF decides the drug; mitral stenosis / mechanical valve → warfarin
TEE Before cardioversion if AF ≥48 h and no 3 weeks of OAC

💊 Management

⌄
1Unstable because of AF?
Yes → Synchronized cardioversion ≥200 J. Start heparin, but do not delay the shock.
No ↓ Go on.
▼
2Is there a cause that needs the tachycardia? (sepsis, bleed, hypovolemia, PE)
Yes → Treat the cause first. Rate drugs can crash the BP.
▼
3Pre-excitation on ECG?
Yes → Procainamide or ibutilide, or DCCV. No BB, CCB, digoxin, adenosine, IV amiodarone.
▼
4What is the EF and BP?
Yes → EF >40% + BP OK → metoprolol or diltiazem · EF ≤40% → amiodarone or digoxin · soft BP → esmolol, amiodarone, digoxin
▼
5Anticoagulation + rate vs rhythm plan
Drug Dose Best for Avoid
Metoprolol tartrate 2.5–5 mg IV over 2 min q5 min (max 15 mg); PO 25–100 mg BID Most patients, ACS, thyroid Decompensated HF, hypotension
Diltiazem 0.25 mg/kg IV (~15–20 mg) over 2 min; repeat 0.35 mg/kg; drip 5–15 mg/h EF >40%, COPD EF ≤40%, hypotension
Esmolol 500 mcg/kg over 1 min → 50–300 mcg/kg/min Borderline BP Often needs ICU
Digoxin 0.25 mg IV q2h, max 1.5 mg/24 h HFrEF, soft BP Slow onset; CKD; with amiodarone
Amiodarone 150 mg IV/10 min → 1 mg/min ×6 h → 0.5 mg/min ×18 h Shock, HFrEF Can cardiovert → stroke risk

Do not stack IV diltiazem + metoprolol + amiodarone in one hour. Go oral early.

  • Consider when: first symptomatic episode, HFrEF / suspected tachycardia-mediated cardiomyopathy, rate control fails, younger patient, early AF (EAST-AFNET 4).
  • Cardioversion rules: AF ≥48 h or unknown → 3 weeks of OAC or TEE first. After any cardioversion → OAC ≥4 weeks.
  • Drugs: amiodarone (structural disease OK) · flecainide/propafenone only without CAD/structural disease (+ AV nodal blocker) · dofetilide/sotalol need inpatient QTc monitoring.
  • Ablation: first-line for selected symptomatic patients; improves outcomes in HFrEF (CASTLE-AF).
CHA₂DS₂-VASc Points
CHF / EF ≤40% 1
Hypertension 1
Age ≥75 2
Diabetes 1
Stroke / TIA / embolism 2
Vascular disease 1
Age 65–74 1
Female sex 1
  • ACC/AHA 2023: OAC if ≥2 (men) / ≥3 (women). ESC 2024 uses CHA₂DS₂-VA (no sex point): OAC if ≥2.
  • DOAC over warfarin — except mechanical valve or moderate–severe mitral stenosis.
  • Apixaban 5 mg BID; reduce to 2.5 mg if 2 of 3: age ≥80, weight ≤60 kg, Cr ≥1.5.
  • HAS-BLED finds fixable bleeding risks. Falls alone rarely justify no OAC. Aspirin is not stroke prevention.
  • HCM + AF → anticoagulate regardless of score.
💊 Dose check

Doses are typical adult doses with normal kidney and liver function. Check the dose in CKD, liver disease, frailty or low weight.

⚠️ Pitfalls

⌄
  • Shooting the fire alarm — HR 135 in septic shock is compensatory. Diltiazem → hypotension.
  • Forgetting that amiodarone can cardiovert → same clot risk as DCCV.
  • Diltiazem in HFrEF — negative inotrope.
  • Calling every troponin bump an NSTEMI.
  • Not replacing K and Mg.
  • No anticoagulation plan (or insurance check) at discharge.

🎓 Board corner

⌄
Stem clue Answer
AF, BP 78/40, confused, HR 170 Synchronized cardioversion now
Irregular, >250/min, wide QRS changing shape Pre-excited AF → procainamide / DCCV
AF + EF 30% — which rate drug to avoid? Diltiazem / verapamil
AF + mechanical mitral valve Warfarin, not DOAC
Unknown duration, wants cardioversion 3 weeks OAC or TEE; OAC ≥4 weeks after
Regular narrow tachycardia at exactly 150 Think 2:1 atrial flutter
Starting amiodarone in a patient on digoxin Cut digoxin dose
Life-threatening bleed on dabigatran Idarucizumab

🏠 Discharge checklist

⌄
  • ☐ Resting HR <110 on a stable oral regimen
  • ☐ Trigger found and treated (infection, thyroid, alcohol, lytes)
  • ☐ TTE done or scheduled
  • ☐ OAC decided, started, covered by insurance; patient taught
  • ☐ Cardiology/EP follow-up in 1–2 weeks; ablation discussed
  • ☐ OSA screen, weight, BP, alcohol counseling

📚 References

⌄
  • Joglar JA, et al. 2023 ACC/AHA/ACCP/HRS Guideline for AF. Circulation. 2024;149:e1–e156.
  • Van Gelder IC, et al. 2024 ESC Guidelines for AF. Eur Heart J. 2024.
  • 2025 AHA Guidelines for CPR and ECC — Adult ALS (cardioversion energies).
  • RACE II (NEJM 2010) · EAST-AFNET 4 (NEJM 2020) · CASTLE-AF (NEJM 2018).
↩︎ Back to ❤️ Cardiology & EP